PAN3 and colon adenocarcinoma: Unexpectedly, our study found that all the prognostic predictors were poor in COAD patients with high expression of PAN3-AS1, suggesting that PAN3-AS1 might be a reliable biomarker for COAD patients’ prognosis analysis.